These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9015369)

  • 21. C1 inhibitor: different mechanisms of reaction with complement component C1 and C1s.
    Hortin GL; Trimpe BL
    Immunol Invest; 1991 Feb; 20(1):75-82. PubMed ID: 2055603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
    Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
    J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.
    He S; Sim RB; Whaley K
    Mol Med; 1998 Feb; 4(2):119-28. PubMed ID: 9508789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1, the first component of complement: structure-function-relationship of C1q and collectins (MBP, SP-A, SP-D, conglutinin), C1-esterases (C1r and C1s), and C1-inhibitor in health and disease.
    Loos M; Colomb M
    Behring Inst Mitt; 1993 Dec; (93):1-5. PubMed ID: 8172555
    [No Abstract]   [Full Text] [Related]  

  • 25. Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases.
    Björk I; Nordling K; Raub-Segall E; Hellman U; Olson ST
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):701-9. PubMed ID: 9794814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A simplified method for the assessment of C1 esterase inhibitor function].
    Deguchi M; Takemura S; Ueda M; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
    Ryumachi; 1990 Jun; 30(3):166-71. PubMed ID: 2244251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
    Wuillemin WA; te Velthuis H; Lubbers YT; de Ruig CP; Eldering E; Hack CE
    J Immunol; 1997 Aug; 159(4):1953-60. PubMed ID: 9257861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
    Nilsson T; Bäck O
    Clin Exp Immunol; 1985 Apr; 60(1):178-82. PubMed ID: 3874014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
    Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactive oxygen species cause direct damage of Engelbreth-Holm-Swarm matrix.
    Riedle B; Kerjaschki D
    Am J Pathol; 1997 Jul; 151(1):215-31. PubMed ID: 9212747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s.
    Nilsson T; Wiman B
    Eur J Biochem; 1983 Jan; 129(3):663-7. PubMed ID: 6297891
    [No Abstract]   [Full Text] [Related]  

  • 33. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
    Zahedi R; Wisnieski J; Davis AE
    J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor.
    Knauer DJ; Majumdar D; Fong PC; Knauer MF
    J Biol Chem; 2000 Dec; 275(48):37340-6. PubMed ID: 10973954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C1-inhibitor-serine proteinase complexes and the biosynthesis of C1-inhibitor by Hep G2 and U 937 cells.
    Patston PA; Medcalf RL; Kourteva Y; Schapira M
    Blood; 1993 Dec; 82(11):3371-9. PubMed ID: 8241507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of Bartonella henselae to extracellular molecules: identification of potential adhesins.
    Dabo SM; Confer AW; Saliki JT; Anderson BE
    Microb Pathog; 2006 Jul; 41(1):10-20. PubMed ID: 16725305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.
    Chaillan-Huntington CE; Gettins PG; Huntington JA; Patston PA
    Biochemistry; 1997 Aug; 36(31):9562-70. PubMed ID: 9236002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping the binding site of C1-inhibitor for polyanion cofactors.
    Hor L; Pan J; Whisstock JC; Pike RN; Wijeyewickrema LC
    Mol Immunol; 2020 Oct; 126():8-13. PubMed ID: 32717572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism.
    Brown EW; Ravindran S; Patston PA
    Blood Coagul Fibrinolysis; 2002 Dec; 13(8):711-4. PubMed ID: 12441910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.